Searchable abstracts of presentations at key conferences in endocrinology

ea0025p13 | Bone | SFEBES2011

What predicts adverse outcomes in untreated primary hyperparathyroidism?

Yu Ning , Donnan Peter , Leese Graham

Context: Rising evidence of the increased risk in mild PHPT suggests that serum calcium, which has been a main surgical criterion, maybe not an accurate indicator of disease severity or at least, not a reliable predictive factor of its long-term consequences. This study aims to identify the best biochemical predictor of adverse outcomes in untreated PHPT.Outcome measures and methods: Primary outcomes considered were all-cause mortality, fatal and non-fat...

ea0025p67 | Clinical biochemistry | SFEBES2011

Status epilepticus in addisonian crisis

El-Mahmoudi Bashir , Yaacoub Gabreil , Hussain Mureed

A 76-year-old man with history of oesophageal carcinoma was successfully treated by surgery and radiotherapy 4 years previously. He presented with anorexia and 4 stones weight loss associated with abdominal discomfort. He was not on any medication. On examination blood pressure 100/60, no peripheral oedema, systemic examination otherwise was unremarkable. Soon after admission, he developed a generalised tonic clonic seizure requiring a Lorazepam and Phenytoin infusion to contr...

ea0025p193 | Endocrine tumours and neoplasia | SFEBES2011

Prevalence and follow-up of adrenal incidentalomas after CT renal colic

Koulouri Olympia , Turner Lisa , Tarigopula Giridhar , Kong Marie-France

Introduction: CT renal tract is commonly requested by the urologists for suspected renal colic as it is recognized as the most accurate technique for the detection of ureteric stones. However, follow-up of adrenal incidentalomas identified on such scans could pose a challenge for the non-endocrinologist. We investigated the prevalence and follow-up of incidentally discovered adrenal masses after CT renal colic.Methods: We looked through the reports of al...

ea0025p196 | Endocrine tumours and neoplasia | SFEBES2011

MEN-1 mosaic: the founder of a family

Farook Seleena , Kannappan Daniel , Kenz Sami , Lalloo Fiona , Trainer Peter , Brabant Georg

Multiple endocrine neoplasia 1 (MEN-1) is an inherited autosomal dominant tumour syndrome affecting mainly the parathyroid gland, pituitary and pancreas. Genetic defect appears to be deletion mutation of MEN1 gene coding for tumour suppression. We describe a case of MEN1 mosaic mutation never reported in the literature.The index case presented aged 52 in 1985 with headaches and dizziness when hypercalcemia of 3.2 mmol/l was noted. Past medical history in...

ea0025p303 | Steroids | SFEBES2011

Accidental long-term ingestion of androgenic steroid in a young female: a case report

Katreddy Venkata , Dale Jane , Siddique Haroon

Aim: We present an unusual case of long-term accidental ingestion of androgenic steroid in a young female.Case: A 28-year-old lady presented with male pattern of hair growth, weight gain of three stones, change in voice, and secondary amenorrhea. On direct questioning she admitted she was taking ‘fat bursting pills’ for nearly 6 months, obtained from a gym, to lose weight. Examination revealed a blood pressure of 150/77 mmHg, increased muscle b...

ea0022p192 | Clinical case reports and clinical practice | ECE2010

Approaches to the diagnosis and management of primary hyperparathyroidism in Europe results from a European Survey in five countries

Ralston Stuart , Langdahl Bente

Background: Primary hyperparathyroidism (PHPT) is a common condition, which in some patients can lead to complications such as osteoporosis and renal stones. This survey investigated diagnosis and treatment strategies for PHPT across Europe.Methods: The survey was conducted in five European countries (France, Germany, UK, Italy and Spain). 286 of the 421 interviewed physicians were endocrinologists; the remainder were rheumatologists (46), internists (50...

ea0022p438 | Endocrine tumours &amp; neoplasia (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Gonadotrophinoma and parathyroid adenoma

Chronaiou Aikaterini , Kostoglou-Athanassiou Ifigenia , Klangos Georgios , Stefanopoulos Dimitris , Michou Aikaterini , Alexandros Badila Razvan , Kotanoglou Stylianos , Karfi Areti

The coexistence of multiple adenomas in endocrine glands has been described in the context of the syndromes of multiple endocrine neoplasia. However, recently the presence of adenomas in multiple endocrine glands has been described in patients not fulfilling the criteria of the syndromes of multiple endocrine neoplasia.The aim was to describe the case of a patient with a pituitary gonadotrophinoma who presented with primary hyperparathyroidism caused by ...

ea0022p452 | Endocrine tumours &amp; neoplasia (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Cushing’s disease as the first manifestation of familial multiple endocrine neoplasia syndrome type 1

Rostomyan Liliya , Mokrysheva Natalya , Tiulpakov Anatoly , Rozhinskaya Ludmila

MEN1 syndrome is an autosomal dominant inherited disease characterised by primary hyperparathyroidism in association with endocrine enteropancratic tumors and anterior pituitary adenomas. Tumours of the pituitary gland as the first manifestations of MEN1 are very rare in children.Clinical case report: A 13-year-old boy presented with clinical signs suggestive of Cushing’s syndrome. He had decreased growth rate, muscle weakness, headaches and truncal...

ea0021cm1.2 | Long-term consequences of endocrine diseases | SFEBES2009

Mild primary hyperparathyroidism

Selby Peter

Primary hyperparathyroidism (PHP) is one of the most common endocrine diseases; it is frequently found in asymptomatic patients when there is some doubt as to the appropriate choice of surgery (PTX), medical therapy or watchful waiting. These decisions are generally based on the consensus guidelines produced by the NIH however there is concern that these reflect established medical/surgical practice in the USA as much as clinical evidence. What evidence that does exist is freq...

ea0019s16 | Calcium conundrums: too high, too low and what to do | SFEBES2009

Familial benign hypocalciuric hypercalcaemia – an update

Brixen Kim

Familial benign hypocalciuric hypercalcaemia (FHH) is a lifelong, benign, inherited condition with slightly increased levels of plasma calcium, low urinary calcium excretion, and normal to moderately elevated plasma parathyroid hormone (PTH). In most cases, FHH (type-1) is caused by inactivating mutations in the gene encoding the calcium sensing receptor (CASR) expressed in the parathyroids and the kidneys. The estimated prevalence of FHH is 1 in 78 000 compared with that of p...